{"result": "(\"entity\"<|>ALBACETE<|>GEO<|>Albacete is a city in Spain where the FRADEA study on frailty and dependence was conducted.)\n##\n(\"entity\"<|>FRADEA STUDY<|>EVENT<|>The FRADEA study investigates frailty and dependence in older adults in Albacete.)\n##\n(\"entity\"<|>CLEG A<|>PERSON<|>Clegg A is a researcher who contributed to the study of frailty in elderly people published in The Lancet.)\n##\n(\"entity\"<|>CRUZ-JENTOFT AJ<|>PERSON<|>Cruz-Jentoft AJ is a researcher involved in defining and diagnosing sarcopenia.)\n##\n(\"entity\"<|>DRUBBEL I<|>PERSON<|>Drubbel I is a researcher who conducted a systematic review on screening for frailty in primary care.)\n##\n(\"entity\"<|>ELLIS G<|>PERSON<|>Ellis G is a researcher who performed a meta-analysis on comprehensive geriatric assessment for older adults.)\n##\n(\"entity\"<|>ENSRUD KE<|>PERSON<|>Ensrud KE is a researcher who studied frailty and its risks in older women.)\n##\n(\"entity\"<|>FERRUCCI L<|>PERSON<|>Ferrucci L is a researcher focused on designing trials to prevent functional decline in frail older persons.)\n##\n(\"entity\"<|>FIATARONE MA<|>PERSON<|>Fiatarone MA is a researcher who studied exercise training and nutritional supplementation for physical frailty.)\n##\n(\"entity\"<|>FRIED LP<|>PERSON<|>Fried LP is a researcher who contributed to the understanding of frailty in older adults.)\n##\n(\"entity\"<|>GORDON AL<|>PERSON<|>Gordon AL is a researcher discussing the implications of defining physical frailty.)\n##\n(\"entity\"<|>JONES DM<|>PERSON<|>Jones DM is a researcher who operationalized a frailty index from a comprehensive geriatric assessment.)\n##\n(\"entity\"<|>KIM H<|>PERSON<|>Kim H is a researcher who assessed frailty in a geriatric outpatient clinic.)\n##\n(\"entity\"<|>LAOSA O<|>PERSON<|>Laosa O is a researcher focused on pharmaceutical interventions for frailty and sarcopenia.)\n##\n(\"entity\"<|>MORLEY JE<|>PERSON<|>Morley JE is a researcher who called for action on frailty consensus.)\n##\n(\"entity\"<|>OTERO A<|>PERSON<|>Otero A is a researcher who studied frailty screening in primary care.)\n##\n(\"entity\"<|>RIZZOLI R<|>PERSON<|>Rizzoli R is a researcher discussing quality of life in sarcopenia and frailty.)\n##\n(\"entity\"<|>ROCKWOOD K<|>PERSON<|>Rockwood K is a researcher who has extensively studied frailty in elderly people.)\n##\n(\"entity\"<|>RODRIGUEZ MANAS L<|>PERSON<|>Rodriguez Manas L is a researcher involved in stimulating research on aging and frailty in Spain.)\n##\n(\"relationship\"<|>FRADEA STUDY<|>ALBACETE<|>The FRADEA study was conducted in Albacete, focusing on frailty and dependence<|>8)\n##\n(\"relationship\"<|>CLEG A<|>FRADEA STUDY<|>Cleg A contributed to the research findings of the FRADEA study<|>7)\n##\n(\"relationship\"<|>CRUZ-JENTOFT AJ<|>FRADEA STUDY<|>Cruz-Jentoft AJ's work on sarcopenia is relevant to the themes of the FRADEA study<|>5)\n##\n(\"relationship\"<|>DRUBBEL I<|>FRADEA STUDY<|>Drubbel I's systematic review on frailty screening relates to the FRADEA study's focus<|>5)\n##\n(\"relationship\"<|>ELLIS G<|>FRADEA STUDY<|>Ellis G's meta-analysis on geriatric assessment is relevant to the FRADEA study<|>5)\n##\n(\"relationship\"<|>ENSRUD KE<|>FRADEA STUDY<|>Ensrud KE's research on frailty risks complements the FRADEA study<|>5)\n##\n(\"relationship\"<|>FERRUCCI L<|>FRADEA STUDY<|>Ferrucci L's work on preventing functional decline is related to the FRADEA study<|>5)\n##\n(\"relationship\"<|>FIATARONE MA<|>FRADEA STUDY<|>Fiatarone MA's research on frailty interventions is relevant to the FRADEA study<|>5)\n##\n(\"relationship\"<|>FRIED LP<|>FRADEA STUDY<|>Fried LP's contributions to frailty research are pertinent to the FRADEA study<|>5)\n##\n(\"relationship\"<|>GORDON AL<|>FRADEA STUDY<|>Gordon AL's discussions on frailty definitions relate to the FRADEA study<|>5)\n##\n(\"relationship\"<|>JONES DM<|>FRADEA STUDY<|>Jones DM's operationalization of a frailty index is relevant to the FRADEA study<|>5)\n##\n(\"relationship\"<|>KIM H<|>FRADEA STUDY<|>Kim H's frailty assessment work is related to the FRADEA study<|>5)\n##\n(\"relationship\"<|>LAOSA O<|>FRADEA STUDY<|>Laosa O's research on pharmaceutical interventions connects to the FRADEA study<|>5)\n##\n(\"relationship\"<|>MORLEY JE<|>FRADEA STUDY<|>Morley JE's call to action on frailty is relevant to the FRADEA study<|>5)\n##\n(\"relationship\"<|>OTERO A<|>FRADEA STUDY<|>Otero A's work on frailty screening is related to the FRADEA study<|>5)\n##\n(\"relationship\"<|>RIZZOLI R<|>FRADEA STUDY<|>Rizzoli R's research on quality of life in frailty is relevant to the FRADEA study<|>5)\n##\n(\"relationship\"<|>ROCKWOOD K<|>FRADEA STUDY<|>Rockwood K's extensive research on frailty is pertinent to the FRADEA study<|>5)\n##\n(\"relationship\"<|>RODRIGUEZ MANAS L<|>FRADEA STUDY<|>Rodriguez Manas L's work on aging and frailty is relevant to the FRADEA study<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: r Gerontol 2010; 45:106-10.\n\nAbizanda Soler P, LÃ³pez-Torres Hidalgo J, Romero Rizos L, et al. Frailty and dependence in Albacete (FRADEA study): reasoning, design and methodology. Rev Esp Geriatr Gerontol 2011; 46:81-8.\n\nClegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013; 381:752-62.\n\nCruz-Jentoft AJ, Baeyens JP, Bauer JM, Y, et al. Zamboni, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age ageing 2010; 39:412-23.\n\nDrubbel I, Numans ME, Kranenburg G, et al. Screening for frailty in primary care: a systematic review of the psychometric properties of the frailty index in community-dwelling older people. BMC Geriatr 2014; 14:27.\n\nEllis G, Whitehead MA, Robinson D, et al. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 2011; 343:d6553.\n\nEnsrud KE, Ewing SK, Taylorn BC, et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007; 62:744-51.\n\nFerrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatrics Soc 2004; 52:625-34.\n\nFiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1995; 330:1.769-75.\n\nFried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59:255-63.\n\nFried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146-56.\n\nGordon AL, Masud T, Gladman JR. Now that we have a definition for physical frailty, what shape should frailty medicine take? Age Ageing 2014; 43:8-9.\n---\nJones DM, Song X, RockwoodK. Operationalizing a frailty index from a standardized com-\nprehensive geriatric assessment. J Am Geriatr Soc 2004; 52:1.929-33.\n\nKim H, Higgins PA, Canaday DH, Burant CJ, Hornick TR. Frailty assessment in the geriatric\noutpatient clinic. Geriatr Gerontol Int 2014; 14:78-83.\n\nLaosa O, Alonso C, Castro M, Rodriguez-Manas L. Pharmaceutical Interventions For Frailty\nAnd Sarcopenia. Curr Pharm Des 2013.\n\nMorley JE, Vellas B, Van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc\n2013; 14:392-7.\n\nMorley JE, Von Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less\ntraveled. J Cachexia Sarcopenia Muscle 2014; 5:5-8.\n\nOtero A, Castell MV, De Hoyos MC. Frailty screening in primary care. Rev Esp Geriatr y\nGerontol 2011; 46:239-40.\n\nRizzoli R, Reginster JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue int\n2013; 93:101-20.\n\nRockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving\nconcept. CMAJ 1994; 150:489-95.\n\nRockwood K, Howlett SE, MacKnight C, et al. Prevalence, attributes, and outcomes of fit-\nness and frailty in community-dwelling older adults: report from the Canadian study of\nhealth and aging. J Gerontol A Biol Sci Med Sci 2004; 59:1.310-7.\n\nRockwood K, Hubbard R. Frailty and the geriatrician. Age Ageing 2004; 33:429-30.\n\nRockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in\nelderly people. CMAJ 2005; 173:489-95.\n\nRodriguez Manas L. RETICEF: an opportunity to stimulate Spanish research on ageing and\nfrailty. Revista Esp Geriatr Gerontol 2008; 43:68-70.\n\nRodriguez-Manas L, Feart C, Mann G, et al. Searching for an operational definition of frailty:\na Delphi method based consensus statement: the frailty operative definition-consensus con-\nference project\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}